|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008838,
umls-concept:C0013089,
umls-concept:C0013216,
umls-concept:C0015385,
umls-concept:C0025677,
umls-concept:C0029463,
umls-concept:C0030705,
umls-concept:C0205225,
umls-concept:C0205462,
umls-concept:C0332293,
umls-concept:C0683956,
umls-concept:C0871261,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2603343,
umls-concept:C2911692
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1998-3-2
|
|
pubmed:abstractText |
In osteosarcoma of the extremity, a strong correlation between chemotherapy-induced necrosis and prognosis has been reported. The aim of this study was to investigate the possible factors that influence histologic response to primary chemotherapy.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:BacchiniPP,
pubmed-author:BacciGG,
pubmed-author:BertoniFF,
pubmed-author:Brach del PreverAA,
pubmed-author:CampanacciMM,
pubmed-author:ComandoneAA,
pubmed-author:DelepineNN,
pubmed-author:FerrariSS,
pubmed-author:MercuriMM,
pubmed-author:PiccoVV,
pubmed-author:TienghiAA
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
658-63
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9469355-Adolescent,
pubmed-meshheading:9469355-Adult,
pubmed-meshheading:9469355-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:9469355-Bone Neoplasms,
pubmed-meshheading:9469355-Cisplatin,
pubmed-meshheading:9469355-Doxorubicin,
pubmed-meshheading:9469355-Extremities,
pubmed-meshheading:9469355-Female,
pubmed-meshheading:9469355-Humans,
pubmed-meshheading:9469355-Male,
pubmed-meshheading:9469355-Methotrexate,
pubmed-meshheading:9469355-Osteosarcoma,
pubmed-meshheading:9469355-Retrospective Studies
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Predictive factors of histologic response to primary chemotherapy in osteosarcoma of the extremity: study of 272 patients preoperatively treated with high-dose methotrexate, doxorubicin, and cisplatin.
|
|
pubmed:affiliation |
Service de Pediatrie, Medecin Interne Oncologique, Hopital Robert Debré, Paris, France. stafflab@oncolabvrizzoli.tizeta.it
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
